Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jed A Katzel

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Journal of the National Cancer Institute|December 21, 2019
Oral Leukoplakia and Risk of Progression to Oral Cancer: A Population-Based Cohort StudyAnil K Chaturvedi, Natalia Udaltsova, Eric A Engels, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|July 23, 2024
Impact of pharmacist managed oral epidermal growth factor receptor inhibitorsShirley Ng, Nicholas Baker, Fang Niu, et al.
American Journal of Hematology|October 22, 2008
Therapy-related leukemia in patients with human immunodeficiency virus infection after treatment for non-Hodgkin lymphomaJed A Katzel, Sanford J Kempin, Portia Lagmay-Fuentes, et al.
The Permanente Journal|August 28, 2023
Real-World Use of Electronic Patient-Reported Outcome (ePRO) Tools Integrated in the Electronic Medical Record During Radiation Therapy for Head and Neck Cancer: Feasibility StudyJed A Katzel, Stephen K Van Den Eeden, Raymond Liu, et al.
Journal of the National Cancer Institute|December 4, 2025
Cisplatin during radiation for head and neck cancer: insights from NRG Oncology experienceLuana G Sousa, James Edward Bates, Payal Anand, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Journal of the National Cancer Institute|December 21, 2019
Oral Leukoplakia and Risk of Progression to Oral Cancer: A Population-Based Cohort StudyAnil K Chaturvedi, Natalia Udaltsova, Eric A Engels, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|July 23, 2024
Impact of pharmacist managed oral epidermal growth factor receptor inhibitorsShirley Ng, Nicholas Baker, Fang Niu, et al.
American Journal of Hematology|October 22, 2008
Therapy-related leukemia in patients with human immunodeficiency virus infection after treatment for non-Hodgkin lymphomaJed A Katzel, Sanford J Kempin, Portia Lagmay-Fuentes, et al.
The Permanente Journal|August 28, 2023
Real-World Use of Electronic Patient-Reported Outcome (ePRO) Tools Integrated in the Electronic Medical Record During Radiation Therapy for Head and Neck Cancer: Feasibility StudyJed A Katzel, Stephen K Van Den Eeden, Raymond Liu, et al.
Journal of the National Cancer Institute|December 4, 2025
Cisplatin during radiation for head and neck cancer: insights from NRG Oncology experienceLuana G Sousa, James Edward Bates, Payal Anand, et al.
Pageof 2